At a glance
- Originator Novartis
- Class Antidepressants; Antiparkinsonians; Neuroprotectants; Nootropics
- Mechanism of Action Catechol O-methyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 19 Jul 2010 Discontinued - Phase-I for Parkinson's disease in Germany (PO)
- 19 Jul 2010 Discontinued - Phase-I for Parkinson's disease in Switzerland (PO)
- 13 Sep 1995 Suspended-I for Parkinson's disease in Germany (PO)